Trademark Overview
On Tuesday, November 19, 2024, a trademark application was filed for MERIBEL PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the MERIBEL PHARMACEUTICALS trademark a serial number of 98860850. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 19, 2024. This trademark is owned by BW CDMO Holdings UK Limited. The MERIBEL PHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of pharmaceuticals; custom manufacture of medicines and vaccines; custom manufacture of products relating to biotechnology; custom manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; custom manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; contract manufacturing services; pharmaceutical contract manufacturing services; biotechnology contract manufacturing services; contract manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infecti...
Pharmaceutical preparations; biological preparations; pharmaceutical substances and preparations; vaccines; vaccine manufacturing preparations; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use; immunotherapeutic drugs; therapeutic and prophylactic pharmaceutical products; gene therapy products; pharmaceuticals in the form of nanoparticles for delivery; pharmaceutical substances and preparations, nanoparticles, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the centr...
Scientific and technological services and research and design relating thereto; industrial analysis services; laboratory services; research and development services; pharmaceutical research and development services; research and development in the biotechnology field; biological research, clinical research and medical research; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; conducting clinical trials; pharmaceutical testing and clinical trials; pharmaceutical drug developments services; research and development of pharmaceutical preparations; research and development of vaccines and medicines; research and development of gene-based medicines; research and laboratory analytic and diagnostic services; design of manufacturing facilities; manufacturing development services; quality control and validation services; genetic engineering laboratories and biochemistry laboratories; product development consultancy in the field of pharm...
